CRS studies for CAR T cell therapy

29 May 2022

In this application note, The Jackson Laboratory (JAX) reviews JAX’s cytokine release syndrome (CRS) evaluation capabilities. Download to see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.

Links

Tags